Literature DB >> 15383162

Comparison of the nucleotide sequence and expression of norA genes and microbial susceptibility in 21 strains of Staphylococcus aureus.

Norihisa Noguchi1, Hiroyuki Okada, Koji Narui, Masanori Sasatsu.   

Abstract

The norA gene, which is located on the chromosome of Staphylococcus aureus, encodes the multidrug efflux protein with 12 transmembrane segments (TMS), and the overexpression of norA by the mutation of the transcriptional control region confers resistance to fluoroquinolones and antiseptics. In this study, the nucleotide sequence and transcriptional expression of norA genes were studied in six standard laboratory strains and 15 clinical isolates, which included 5 antiseptic-susceptible strains and 10 resistant strains. Seven mutations leading to up-regulation of norA transcription were identified. In addition, a novel allele of norA (norAII) was identified whose 3'-terminal region sequence and profile of antimicrobial susceptibility differs from those of original norA. Copyright Mary Ann Liebert, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383162     DOI: 10.1089/mdr.2004.10.197

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  12 in total

Review 1.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

2.  Antimicrobial agent of susceptibilities and antiseptic resistance gene distribution among methicillin-resistant Staphylococcus aureus isolates from patients with impetigo and staphylococcal scalded skin syndrome.

Authors:  Norihisa Noguchi; Hidemasa Nakaminami; Setsuko Nishijima; Ichiro Kurokawa; Hiromu So; Masanori Sasatsu
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Recurrent Methicillin-Resistant Staphylococcus aureus Cutaneous Abscesses and Selection of Reduced Chlorhexidine Susceptibility during Chlorhexidine Use.

Authors:  Ryan C Johnson; Carey D Schlett; Katrina Crawford; Jeffrey B Lanier; D Scott Merrell; Michael W Ellis
Journal:  J Clin Microbiol       Date:  2015-08-19       Impact factor: 5.948

4.  Candidate targets of balancing selection in the genome of Staphylococcus aureus.

Authors:  Jonathan C Thomas; Paul A Godfrey; Michael Feldgarden; D Ashley Robinson
Journal:  Mol Biol Evol       Date:  2011-11-22       Impact factor: 16.240

Review 5.  Multidrug efflux pumps in Staphylococcus aureus and their clinical implications.

Authors:  Soojin Jang
Journal:  J Microbiol       Date:  2016-01-05       Impact factor: 3.422

6.  Identification and characterization of TriABC-OpmH, a triclosan efflux pump of Pseudomonas aeruginosa requiring two membrane fusion proteins.

Authors:  Takehiko Mima; Swati Joshi; Margarita Gomez-Escalada; Herbert P Schweizer
Journal:  J Bacteriol       Date:  2007-08-24       Impact factor: 3.490

7.  Postantibiotic effects and bactericidal activities of levofloxacin and gatifloxacin at concentrations simulating those of topical ophthalmic administration against fluoroquinolone-resistant and fluoroquinolone-sensitive methicillin-resistant Staphylococcus aureus strains.

Authors:  Saichi Hoshi; Ken Kikuchi; Takashi Sasaki; Chie Sotozono; Shigeru Kinoshita; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2008-05-19       Impact factor: 5.191

Review 8.  Antimicrobial resistance (AMR) nanomachines-mechanisms for fluoroquinolone and glycopeptide recognition, efflux and/or deactivation.

Authors:  Mary K Phillips-Jones; Stephen E Harding
Journal:  Biophys Rev       Date:  2018-03-10

9.  Multidrug Efflux Pumps in Staphylococcus aureus: an Update.

Authors:  Sofia Santos Costa; Miguel Viveiros; Leonard Amaral; Isabel Couto
Journal:  Open Microbiol J       Date:  2013-03-22

10.  Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets.

Authors:  Lauren E Brooks; Sabah Ul-Hasan; Benjamin K Chan; Mark J Sistrom
Journal:  mSystems       Date:  2018-04-17       Impact factor: 6.496

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.